Catherine Owen Adams Salary and Compensation - ACADIA PHARMACEUTICALS INC CEO Salary 2025

In fiscal year 2025, Catherine Owen Adams, Chief Executive Officer of ACADIA PHARMACEUTICALS INC (ACAD), received total compensation of $8.3 million.

Catherine Owen Adams's compensation breakdown includes: base salary of $930K, stock awards valued at $3.2 million, option awards of $3.2 million, non-equity incentive compensation of $819K, and other compensation of $33K.

Compared to fiscal year 2024, Catherine Owen Adams's total compensation increased 9% from $7.6 million to $8.3 million.

ACADIA PHARMACEUTICALS INC (ACAD) Executive Pay 2025

ACADIA PHARMACEUTICALS INC's top 5 named executive officers received combined total compensation of $18.0 million in fiscal year 2025.

The named executive officers disclosed in ACADIA PHARMACEUTICALS INC's 2025 proxy statement are:Catherine Owen Adams (Chief Executive Officer) with total compensation of $8.3 million, Mark C. Schneyer (Executive Vice President, Chief Financial Officer) with total compensation of $3.1 million, Jennifer J. Rhodes (Executive Vice President, Chief Legal Officer and Secretary) with total compensation of $2.9 million, Elizabeth H.Z. Thompson (Executive Vice President, Head of Research and Development) with total compensation of $2.9 million, and Thomas Garner (Executive Vice President, Chief Commercial Officer) with total compensation of $857K.